Lidocaine and Triamcinolone vs Saline Trigger Point Injection for Treatment of Chronic Abdominal Wall Pain
WithdrawnPhase 4NCT02748395
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
The purpose of this study is to determine whether the injection of triamcinolone and lidocaine is effective in relieving chronic abdominal wall pain.
Study details
- Official title
- Lidocaine and Triamcinolone vs Saline Trigger Point Injection for Treatment of Chronic Abdominal Wall Pain
- Conditions
- Chronic Abdominal Wall Pain
- Abdominal Cutaneous Nerve Entrapment Syndrome
- Interventions
- Sponsor
- Temple University
- Start date
- 2016-05
- Primary completion
- 2016-12
- Sex
- All
- Age range
- from 18 Years
- Results posted
- No results posted in this snapshot
- Total sites listed
- 0
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * Clinical diagnosis of chronic abdominal wall pain * Prior ultrasound or cross-sectional imaging of the abdomen to exclude other causes * Baseline Brief Pain Inventory score ≥ 5 Exclusion Criteria: * Multiple trigger points * Abdominal wall hernia on exam * Weight loss * Rectal bleeding * Recent change in bowel habits * Decompensated cirrhosis or recurrent ascites * Allergy or contraindication to study medications * Known thrombocytopenia with platelet count \< 50,000 * Other diagnosis of chronic pain syndromes including fibromyalgia * Unable to provide informed consent * Pregnancy
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT02748395